A detailed history of Missouri Trust & Investment CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Missouri Trust & Investment CO holds 7,129 shares of ABBV stock, worth $1.28 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
7,129
Previous 7,148 0.27%
Holding current value
$1.28 Million
Previous $1.23 Million 14.76%
% of portfolio
0.5%
Previous 0.46%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$163.84 - $199.33 $3,112 - $3,787
-19 Reduced 0.27%
7,129 $1.41 Million
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $11,454 - $13,376
-74 Reduced 1.02%
7,148 $1.23 Million
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $81,188 - $92,506
508 Added 7.57%
7,222 $1.32 Million
Q4 2023

Feb 08, 2024

SELL
$137.6 - $154.97 $1,238 - $1,394
-9 Reduced 0.13%
6,714 $1.04 Million
Q2 2023

Aug 11, 2023

BUY
$132.51 - $164.9 $90,504 - $112,626
683 Added 11.31%
6,723 $905,000
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $56,397 - $64,950
-390 Reduced 6.07%
6,040 $962,000
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $118,946 - $142,648
860 Added 15.44%
6,430 $1.04 Million
Q3 2022

Nov 10, 2022

BUY
$134.21 - $153.93 $126,828 - $145,463
945 Added 20.43%
5,570 $748,000
Q2 2022

Aug 10, 2022

SELL
$137.62 - $174.96 $3,440 - $4,374
-25 Reduced 0.54%
4,625 $708,000
Q1 2022

May 10, 2022

BUY
$131.98 - $163.75 $8,446 - $10,480
64 Added 1.4%
4,650 $754,000
Q4 2021

Feb 02, 2022

BUY
$107.43 - $135.93 $492,673 - $623,374
4,586 New
4,586 $621,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Missouri Trust & Investment CO Portfolio

Follow Missouri Trust & Investment CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Missouri Trust & Investment CO, based on Form 13F filings with the SEC.

News

Stay updated on Missouri Trust & Investment CO with notifications on news.